1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3: Systematic review of the literature for flow diversion of CCAs
Study Total Aneurysms in Study Silk or PED CCAs (No.) Major Morbidity (No.) Mortality (No.)
Berge et al²⁹ 77 Silk 29 3 0
Becske et al^{7,^a} 108 PED 28 1 0
Chan et al³⁰ 13 PED 5 0 0
Chitale et al³¹ 42 PED 16 2 0
Cinar et al³² 55 PED 5 0 0
Fischer et al^{33,^b} 101 PED 15 1 0
Lubicz et al³⁴ 34 Silk 5 1 0
Lylyk et al⁵ 63 PED 11 0 0
McAuliffe et al^{35,^c} 57 PED 11 0 0
Nelson et al⁶ 31 PED 5 0 0
O'Kelly et al⁸ 94 PED 28 0 0
Piano et al³⁶ 104 Silk 16 1 0
PED 
Saatci et al³⁷ 251 PED 28 1 0
Velioglu et al^{38,^d} 87 Silk 19 0 1
Yu et al^{27,^e} 178 PED 32 1 1
Current study 43 PED 43 1 0
Total 1338 296 12 (4.1%) 2 (0.7%)
PED only 227 7 (3.1%) 1 (0.44%)
0.68 Silk only 53 4 (7.5%) 1 (1.9%)
↵a T. Becske, MD, personal oral communication, April 2013.
↵b H. Henkes, MD, personal e-mail communication, April 2013.
↵c W. McAuliffe, MD, personal e-mail communication, April 2013.
↵d N. Kocer, MD, personal e-mail communication, April 2013.
↵e S.C. Yu, MD, personal e-mail communication, April 2013.